Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.
出版信息
Ann Rheum Dis. 1982;41 Suppl 1(Suppl 1):1-60. doi: 10.1136/ard.41.suppl_1.1-a.
Abstract
摘要
相似文献
1
Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.类风湿关节炎疾病进程改善治疗研讨会：免疫抑制的视角
Ann Rheum Dis. 1982;41 Suppl 1(Suppl 1):1-60. doi: 10.1136/ard.41.suppl_1.1-a.
2
[Immunosuppression in rheumatoid arthritis (author's transl)].
Ryumachi. 1978 Dec;18(6):379-81.
3
New therapeutics in rheumatoid arthritis.类风湿关节炎的新疗法
Rheum Dis Clin North Am. 2006 Feb;32(1):57-74, viii. doi: 10.1016/j.rdc.2005.10.004.
4
[Immunosuppressive therapy].
Rev Infirm. 1984 Jul;34(13):43-6.
5
"Disease-modifying" drugs in rheumatoid arthritis.
Drug Ther Bull. 1985 Dec 30;23(26):101-4.
6
Immunosuppressive therapy in rheumatoid arthritis.类风湿关节炎的免疫抑制治疗。
Acta Med Austriaca. 1988;15(5):137-40.
7
The choice of, and the decision to apply, disease modifying drugs.改变病情药物的选择及应用决策。
Ann Rheum Dis. 1982;41 Suppl 1(Suppl 1):1-2. doi: 10.1136/ard.41.suppl_1.1-b.
8
Immunosuppression in the treatment of rheumatoid arthritis. Basic principles and available substances.
Adv Clin Pharmacol. 1974;6:81-8.
9
Investigational agents for rheumatoid arthritis.类风湿关节炎的研究性药物
Rheum Dis Clin North Am. 1995 Aug;21(3):779-96.
10
[Biological immunosuppression and rheumatoid inflammation].
Rev Esp Reum Enferm Osteoartic. 1977;20(1):47-64.
引用本文的文献
1
Immunosuppressive therapy in the treatment of autoimmune diseases.免疫抑制疗法在自身免疫性疾病治疗中的应用。
Springer Semin Immunopathol. 1984;7(1):69-90. doi: 10.1007/BF01891781.
2
Treatment of systemic lupus erythematosus.
Springer Semin Immunopathol. 1986;9(2-3):271-82. doi: 10.1007/BF02099026.
本文引用的文献
1
Gold Treatment in Rheumatoid Arthritis.类风湿关节炎的金制剂治疗
Ann Rheum Dis. 1945 Jun;4(4):71-5. doi: 10.1136/ard.4.4.71.
2
Treatment of rheumatoid arthritis with nitrogen mustard; preliminary report.用氮芥治疗类风湿性关节炎；初步报告。
J Am Med Assoc. 1951 Dec 8;147(15):1418-9.
3
CYTOLOGICAL STUDY OF THE EFFECT OF CYCLOPHOSPHAMIDE ON THE EPITHELIUM OF THE URINARY BLADDER IN MAN.环磷酰胺对人膀胱上皮作用的细胞学研究
Cancer. 1964 Oct;17:1348-55. doi: 10.1002/1097-0142(196410)17:10<1348::aid-cncr2820171017>3.0.co;2-0.
4
COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.类风湿关节炎的病程与预后。进一步报告。
Ann Rheum Dis. 1964 May;23(3):193-204. doi: 10.1136/ard.23.3.193.
5
THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME.干燥综合征病程中恶性淋巴瘤的发生
Am J Med. 1964 Apr;36:529-40. doi: 10.1016/0002-9343(64)90101-9.
6
Systemic rheumatic disease and malignant lymphoma.系统性风湿性疾病与恶性淋巴瘤。
Arch Intern Med. 1963 Mar;111:330-7. doi: 10.1001/archinte.1963.03620270056009.
7
Chromosome preparations of bone marrow cells without prior in vitro culture or in vivo colchicine administration.未经预先体外培养或体内给予秋水仙碱的骨髓细胞染色体标本制备。
Stain Technol. 1962 Jan;37:17-20. doi: 10.3109/10520296209114563.
8
Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis.硫酸羟氯喹（“纷乐”）治疗类风湿关节炎。
Arthritis Rheum. 1962 Oct;5:502-12. doi: 10.1002/art.1780050507.
9
Inhibition of hemagglutinin formation by thioguanine: dose-time relationships.
Proc Soc Exp Biol Med. 1962 Jul;110:444-7. doi: 10.3181/00379727-110-27544.
10
Chromosome preparations of leukocytes cultured from human peripheral blood.从人外周血培养的白细胞的染色体标本制备。
Exp Cell Res. 1960 Sep;20:613-6. doi: 10.1016/0014-4827(60)90138-5.
Zotero 插件